Skip to content
10-Q

Quarterly Report

Foghorn Therapeutics Inc. FHTX

0001628280-25-049238

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 56.55M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.03M sh
Shares Diluted Q3 2025 · Sep 30, 2025 62.95M sh
Shares Diluted Q3 2025 · Sep 30, 2024 62.6M sh
Shares Diluted Q3 2025 · Sep 30, 2024 52.24M sh
Capex Q3 2025 · Sep 30, 2025 $50K
Capex Q3 2025 · Sep 30, 2024 $427K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$63.83M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$75.89M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $89.33M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $55.45M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $57.68M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$89.66M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$76.66M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$61.65M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$45.53M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$28.29M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$14.32M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$97.49M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$77.19M
Current Liabilities Q3 2025 · Sep 30, 2025 $85.09M
Current Liabilities Q3 2025 · Dec 31, 2024 $66.99M
Total Liabilities Q3 2025 · Sep 30, 2025 $294.62M
Total Liabilities Q3 2025 · Dec 31, 2024 $329.51M
Current Assets Q3 2025 · Sep 30, 2025 $184.12M
Current Assets Q3 2025 · Dec 31, 2024 $249.6M
Total Assets Q3 2025 · Sep 30, 2025 $204.96M
Total Assets Q3 2025 · Dec 31, 2024 $283.98M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.25
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.84
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.31
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.28
Eps Basic Q3 2025 · Sep 30, 2025 −$0.25
Eps Basic Q3 2025 · Sep 30, 2025 −$0.84
Eps Basic Q3 2025 · Sep 30, 2024 −$0.31
Eps Basic Q3 2025 · Sep 30, 2024 −$1.28
Sga Expense Q3 2025 · Sep 30, 2025 $6.65M
Sga Expense Q3 2025 · Sep 30, 2025 $20.75M
Sga Expense Q3 2025 · Sep 30, 2024 $6.97M
Sga Expense Q3 2025 · Sep 30, 2024 $22.01M
Rd Expense Q3 2025 · Sep 30, 2025 $20M
Rd Expense Q3 2025 · Sep 30, 2025 $63.42M
Rd Expense Q3 2025 · Sep 30, 2024 $24.69M
Rd Expense Q3 2025 · Sep 30, 2024 $74.02M
Net Income Q3 2025 · Sep 30, 2025 −$15.85M
Net Income Q3 2025 · Sep 30, 2025 −$52.62M
Net Income Q3 2025 · Jun 30, 2025 −$17.94M
Net Income Q3 2025 · Mar 31, 2025 −$18.83M
Net Income Q3 2025 · Sep 30, 2024 −$19.12M
Net Income Q3 2025 · Sep 30, 2024 −$67.12M
Net Income Q3 2025 · Jun 30, 2024 −$22.98M
Net Income Q3 2025 · Mar 31, 2024 −$25.02M
Operating Income Q3 2025 · Sep 30, 2025 −$18.5M
Operating Income Q3 2025 · Sep 30, 2025 −$62.51M
Operating Income Q3 2025 · Sep 30, 2024 −$23.85M
Operating Income Q3 2025 · Sep 30, 2024 −$78.68M
Revenue Q3 2025 · Sep 30, 2025 $8.15M
Revenue Q3 2025 · Sep 30, 2025 $21.66M
Revenue Q3 2025 · Sep 30, 2024 $7.81M
Revenue Q3 2025 · Sep 30, 2024 $19.75M